Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q63993208 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010852.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q63993208 | ||
024 | ‡a 0000-0002-4717-9541 ‡2 orcid | ||
024 | ‡a 8901584900 ‡2 scopus | ||
024 | ‡a 57195466502 ‡2 scopus | ||
035 | ‡a (OCoLC)Q63993208 | ||
100 | 0 | ‡a Ana Rocha ‡c researcher ORCID 0000-0002-4717-9541 ‡9 en | |
670 | ‡a Author's Activin A stimulates interleukin 8 and vascular endothelial growth factor release from cultured human endometrial stromal cells: possible implications for the pathogenesis of endometriosis. | ||
670 | ‡a Author's Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma. | ||
670 | ‡a Author's Associação entre lipid accumulation product | ||
670 | ‡a Author's Associação entre lipid accumulation product (LAP) e hirsutismo na síndrome do ovário policístico. | ||
670 | ‡a Author's Barriers and myths that limit the use of intrauterine contraception in nulliparous women: a survey of Brazilian gynaecologists | ||
670 | ‡a Author's Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients. | ||
670 | ‡a Author's Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis | ||
670 | ‡a Author's Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice | ||
670 | ‡a Author's foxl2 and foxl3 are two ancient paralogs that remain fully functional in teleosts | ||
670 | ‡a Author's FOXL2 in human endometrium: hyperexpressed in endometriosis | ||
670 | ‡a Author's Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. | ||
670 | ‡a Author's Increased expression of antimüllerian hormone and its receptor in endometriosis | ||
670 | ‡a Author's Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | ||
670 | ‡a Author's Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries. | ||
670 | ‡a Author's Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center | ||
670 | ‡a Author's Plasma brain-derived neurotrophic factor in women with pelvic pain: a potential biomarker for endometriosis? | ||
670 | ‡a Author's Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. | ||
670 | ‡a Author's Prospective Evaluation of a Panel of Plasma Cytokines and Chemokines as Potential Markers of Pelvic Endometriosis in Symptomatic Women | ||
670 | ‡a Author's Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus | ||
670 | ‡a Author's Safety of hormonal contraception for obese women | ||
670 | ‡a Author's Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization | ||
670 | ‡a Author's Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response | ||
909 | ‡a (scopus) 57195466502 ‡9 1 | ||
909 | ‡a (orcid) 0000000247179541 ‡9 1 | ||
909 | ‡a (scopus) 8901584900 ‡9 1 | ||
919 | ‡a plasmabrainderivedneurotrophicfactorinwomenwithpelvicpainapotentialbiomarkerforendometriosis ‡A Plasma brain-derived neurotrophic factor in women with pelvic pain: a potential biomarker for endometriosis? ‡9 1 | ||
919 | ‡a safetyofhormonalcontraceptionforobesewomen ‡A Safety of hormonal contraception for obese women ‡9 1 | ||
919 | ‡a urocortin2andurocortin3inendometriosisevidenceforapossibleroleininflammatoryresponse ‡A Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response ‡9 1 | ||
919 | ‡a plasmaurocortin1asapreoperativemarkerofendometriosisinsymptomaticwomen ‡A Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. ‡9 1 | ||
919 | ‡a regularmenstrualcyclesdonotruleoutovariandamageinadultwomenwithsystemiclupuserythematosus ‡A Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus ‡9 1 | ||
919 | ‡a prospectiveevaluationofapanelofplasmacytokinesandchemokinesaspotentialmarkersofpelvicendometriosisinsymptomaticwomen ‡A Prospective Evaluation of a Panel of Plasma Cytokines and Chemokines as Potential Markers of Pelvic Endometriosis in Symptomatic Women ‡9 1 | ||
919 | ‡a nonalcoholicfattyliverdiseaseinwomenwithpolycysticovarysyndromeassociatedfactorsandnoninvasivefibrosisstaginginasinglebraziliancenter ‡A Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center ‡9 1 | ||
919 | ‡a nonhormonalandhormonalintrauterinecontraceptionsurveyofpatientsperceptionsin4latinamericancountries ‡A Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries. ‡9 1 | ||
919 | ‡a nonalcoholicfattyliverdiseaseinwomenwithpolycysticovarysyndromesystematicreviewandmetaanalysis ‡A Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. ‡9 1 | ||
919 | ‡a impairedcrhandurocortinexpressionandfunctionineutopicendometriumofwomenwithendometriosis ‡A Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. ‡9 1 | ||
919 | ‡a increasedexpressionofantimullerianhormoneanditsreceptorinendometriosis ‡A Increased expression of antimüllerian hormone and its receptor in endometriosis ‡9 1 | ||
919 | ‡a foxl2andfoxl3are2ancientparalogsthatremainfullyfunctionalinteleosts ‡A foxl2 and foxl3 are two ancient paralogs that remain fully functional in teleosts ‡9 1 | ||
919 | ‡a effectofletrozoleincarcinogenplusestrogeninducedendometrialhyperplasiainmice ‡A Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice ‡9 1 | ||
919 | ‡a foxl2inhumanendometriumhyperexpressedinendometriosis ‡A FOXL2 in human endometrium: hyperexpressed in endometriosis ‡9 1 | ||
919 | ‡a barriersandmythsthatlimittheuseofintrauterinecontraceptioninnulliparouswomenasurveyofbraziliangynaecologists ‡A Barriers and myths that limit the use of intrauterine contraception in nulliparous women: a survey of Brazilian gynaecologists ‡9 1 | ||
919 | ‡a diagnosticvalueofserumactivinaandfollistatinlevelsinwomenwithperitonealovariananddeepinfiltratingendometriosis ‡A Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis ‡9 1 | ||
919 | ‡a chronotropicincompetenceandabnormalautonomicmodulationinambulatorychagasdiseasepatients ‡A Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients. ‡9 1 | ||
919 | ‡a associacaoentrelipidaccumulationproduct ‡A Associação entre lipid accumulation product ‡9 1 | ||
919 | ‡a alteredexpressionofactivincriptoandfollistatinintheendometriumofwomenwithendometrioma ‡A Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma. ‡9 1 | ||
919 | ‡a associacaoentrelipidaccumulationproductlapehirsutismonasindromedoovariopolicistico ‡A Associação entre lipid accumulation product (LAP) e hirsutismo na síndrome do ovário policístico. ‡9 1 | ||
919 | ‡a activinastimulatesinterleukin8andvascularendothelialgrowthfactorreleasefromculturedhumanendometrialstromalcellspossibleimplicationsforthepathogenesisofendometriosis ‡A Activin A stimulates interleukin 8 and vascular endothelial growth factor release from cultured human endometrial stromal cells: possible implications for the pathogenesis of endometriosis. ‡9 1 | ||
919 | ‡a serumantimullerianhormonemeasurementswith2generationassayat2distinctmenstrualcyclephasesforpredictionofcyclecancellationpregnancyandlivebirthafterinvitrofertilization ‡A Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization ‡9 1 | ||
996 | ‡2 BLBNB|000334919 | ||
996 | ‡2 ISNI|0000000497076588 | ||
996 | ‡2 BLBNB|000501301 | ||
996 | ‡2 DBC|87097946585836 | ||
996 | ‡2 LC|nb2014018313 | ||
996 | ‡2 SZ|1186820543 | ||
996 | ‡2 DNB|139111727 | ||
996 | ‡2 PTBNP|1578682 | ||
996 | ‡2 BLBNB|000653772 | ||
996 | ‡2 BLBNB|001574227 | ||
996 | ‡2 ISNI|0000000081843659 | ||
996 | ‡2 PTBNP|230116 | ||
996 | ‡2 PTBNP|228019 | ||
996 | ‡2 BLBNB|000624347 | ||
996 | ‡2 BIBSYS|14056942 | ||
996 | ‡2 PTBNP|97384 | ||
996 | ‡2 LC|n 2024185221 | ||
996 | ‡2 BLBNB|001530912 | ||
996 | ‡2 BLBNB|000382008 | ||
996 | ‡2 LC|n 99901356 | ||
996 | ‡2 PTBNP|1452155 | ||
996 | ‡2 LC|n 98091967 | ||
996 | ‡2 ISNI|000000005939595X | ||
996 | ‡2 RERO|A013847767 | ||
996 | ‡2 LC|nb2023001252 | ||
996 | ‡2 ISNI|0000000114105813 | ||
996 | ‡2 ISNI|0000000070133387 | ||
996 | ‡2 PTBNP|1448200 | ||
996 | ‡2 DNB|1057275107 | ||
996 | ‡2 RERO|A014240873 | ||
996 | ‡2 LC|n 2022254795 | ||
996 | ‡2 PTBNP|912141 | ||
996 | ‡2 ISNI|0000000068780569 | ||
996 | ‡2 BLBNB|000334913 | ||
996 | ‡2 DNB|14006060X | ||
996 | ‡2 PTBNP|57157 | ||
996 | ‡2 BLBNB|000334915 | ||
996 | ‡2 NUKAT|n 2006087655 | ||
996 | ‡2 BLBNB|000231609 | ||
996 | ‡2 LC|nb2018015406 | ||
996 | ‡2 PTBNP|1630075 | ||
996 | ‡2 ISNI|0000000068395660 | ||
996 | ‡2 ISNI|0000000080078369 | ||
996 | ‡2 BLBNB|000266143 | ||
996 | ‡2 LC|n 2022252272 | ||
996 | ‡2 SUDOC|258356510 | ||
996 | ‡2 PTBNP|1359830 | ||
996 | ‡2 DNB|1057430684 | ||
996 | ‡2 PTBNP|1040877 | ||
996 | ‡2 ISNI|0000000070533129 | ||
996 | ‡2 SZ|1186825278 | ||
996 | ‡2 BLBNB|000679089 | ||
996 | ‡2 NSK|000468822 | ||
996 | ‡2 BLBNB|000394765 | ||
996 | ‡2 PTBNP|967240 | ||
996 | ‡2 RERO|A011567280 | ||
996 | ‡2 BLBNB|001122710 | ||
996 | ‡2 ISNI|0000000069831102 | ||
996 | ‡2 BLBNB|001449236 | ||
996 | ‡2 LC|n 2023254392 | ||
996 | ‡2 DNB|131636332 | ||
996 | ‡2 RERO|A017345824 | ||
996 | ‡2 DNB|1174840498 | ||
996 | ‡2 PTBNP|153723 | ||
996 | ‡2 LC|no2003054277 | ||
996 | ‡2 DNB|1020455489 | ||
996 | ‡2 J9U|987009538227305171 | ||
996 | ‡2 SUDOC|198011652 | ||
996 | ‡2 PTBNP|1898135 | ||
996 | ‡2 DNB|1060755645 | ||
996 | ‡2 PTBNP|1413703 | ||
996 | ‡2 ISNI|0000000068592314 | ||
996 | ‡2 ISNI|0000000034462714 | ||
996 | ‡2 ISNI|0000000053876349 | ||
996 | ‡2 PTBNP|1830254 | ||
996 | ‡2 PTBNP|1412097 | ||
996 | ‡2 LC|n 2010201333 | ||
996 | ‡2 PTBNP|1687286 | ||
996 | ‡2 DNB|1104865629 | ||
996 | ‡2 PTBNP|1220110 | ||
996 | ‡2 LC|n 2017251656 | ||
996 | ‡2 BLBNB|000239966 | ||
996 | ‡2 LC|nb2022011336 | ||
996 | ‡2 PTBNP|1453095 | ||
996 | ‡2 PTBNP|61788 | ||
996 | ‡2 BLBNB|001016555 | ||
996 | ‡2 LC|n 97910468 | ||
996 | ‡2 ISNI|0000000040793341 | ||
996 | ‡2 LC|no2018067674 | ||
996 | ‡2 PTBNP|1052342 | ||
996 | ‡2 BNF|18103187 | ||
996 | ‡2 BLBNB|001119230 | ||
996 | ‡2 NKC|ntk20221146843 | ||
996 | ‡2 ISNI|0000000070522083 | ||
996 | ‡2 LC|nb2020001897 | ||
996 | ‡2 PTBNP|1694017 | ||
996 | ‡2 DNB|1186825278 | ||
996 | ‡2 PTBNP|944142 | ||
996 | ‡2 SUDOC|224813013 | ||
996 | ‡2 LC|ns2015000383 | ||
996 | ‡2 SUDOC|187383375 | ||
996 | ‡2 PTBNP|1586724 | ||
996 | ‡2 BLBNB|000334914 | ||
996 | ‡2 PTBNP|1818790 | ||
996 | ‡2 PTBNP|199410 | ||
996 | ‡2 DNB|1057056715 | ||
996 | ‡2 BLBNB|000564367 | ||
996 | ‡2 SUDOC|146944275 | ||
996 | ‡2 BLBNB|000290926 | ||
996 | ‡2 DNB|1186820543 | ||
996 | ‡2 ISNI|0000000041209418 | ||
996 | ‡2 LC|no2022109637 | ||
996 | ‡2 ISNI|0000000070100569 | ||
996 | ‡2 ISNI|0000000044876726 | ||
996 | ‡2 PTBNP|46737 | ||
996 | ‡2 BLBNB|001480899 | ||
996 | ‡2 LC|n 2011015771 | ||
996 | ‡2 PTBNP|1577248 | ||
996 | ‡2 BNE|XX1174298 | ||
996 | ‡2 ISNI|000000006920845X | ||
996 | ‡2 RERO|A014235245 | ||
996 | ‡2 LC|n 2014205883 | ||
996 | ‡2 ISNI|000000043612454X | ||
996 | ‡2 PTBNP|1783540 | ||
996 | ‡2 BLBNB|000404449 | ||
996 | ‡2 ISNI|0000000070397075 | ||
996 | ‡2 NII|DA10921482 | ||
996 | ‡2 BLBNB|001453624 | ||
996 | ‡2 ISNI|0000000070939612 | ||
996 | ‡2 PTBNP|1904017 | ||
996 | ‡2 SUDOC|113338783 | ||
996 | ‡2 PTBNP|1410453 | ||
996 | ‡2 PTBNP|1578838 | ||
996 | ‡2 PTBNP|80391 | ||
996 | ‡2 LC|no2019159476 | ||
996 | ‡2 PTBNP|1438821 | ||
996 | ‡2 LC|n 2022252457 | ||
996 | ‡2 LC|n 99256037 | ||
996 | ‡2 LC|no2004053086 | ||
996 | ‡2 BLBNB|000278255 | ||
996 | ‡2 ISNI|0000000499477318 | ||
996 | ‡2 PTBNP|1818569 | ||
996 | ‡2 ISNI|0000000087663739 | ||
996 | ‡2 PTBNP|1725868 | ||
996 | ‡2 PTBNP|138546 | ||
996 | ‡2 PTBNP|1420730 | ||
996 | ‡2 PTBNP|1930132 | ||
996 | ‡2 LC|no2003103722 | ||
996 | ‡2 PLWABN|9814296351105606 | ||
996 | ‡2 ISNI|0000000444657645 | ||
996 | ‡2 LC|n 2022254217 | ||
996 | ‡2 PTBNP|1303675 | ||
996 | ‡2 BLBNB|000558152 | ||
996 | ‡2 ISNI|0000000379459633 | ||
996 | ‡2 PTBNP|132552 | ||
996 | ‡2 LC|n 2010027049 | ||
996 | ‡2 ISNI|0000000078181383 | ||
996 | ‡2 SUDOC|191828807 | ||
996 | ‡2 ISNI|0000000070830844 | ||
996 | ‡2 LC|n 2004093236 | ||
996 | ‡2 LC|n 2006210805 | ||
996 | ‡2 LC|n 2006219355 | ||
996 | ‡2 BLBNB|001534749 | ||
996 | ‡2 ISNI|0000000444135337 | ||
996 | ‡2 ISNI|0000000118178446 | ||
996 | ‡2 PTBNP|1798102 | ||
996 | ‡2 LC|n 2009051149 | ||
996 | ‡2 ISNI|0000000070404757 | ||
996 | ‡2 DNB|1056236566 | ||
996 | ‡2 PTBNP|1525631 | ||
996 | ‡2 DNB|1056768878 | ||
996 | ‡2 DNB|1147529647 | ||
996 | ‡2 ISNI|000000004149794X | ||
996 | ‡2 LC|n 2023253427 | ||
996 | ‡2 CAOONL|ncf11875857 | ||
996 | ‡2 ISNI|0000000069599622 | ||
996 | ‡2 PTBNP|1687650 | ||
996 | ‡2 ISNI|0000000434623337 | ||
996 | ‡2 PTBNP|1779500 | ||
996 | ‡2 SUDOC|256029776 | ||
996 | ‡2 LC|no2014168180 | ||
996 | ‡2 PTBNP|1216992 | ||
996 | ‡2 SUDOC|258362804 | ||
996 | ‡2 PTBNP|196733 | ||
996 | ‡2 PTBNP|1431020 | ||
996 | ‡2 PTBNP|1339755 | ||
996 | ‡2 DNB|1302565079 | ||
996 | ‡2 BNF|15612743 | ||
996 | ‡2 ISNI|0000000512765235 | ||
996 | ‡2 ISNI|0000000069191555 | ||
996 | ‡2 PTBNP|1211750 | ||
996 | ‡2 PTBNP|1185586 | ||
996 | ‡2 ISNI|0000000033950855 | ||
996 | ‡2 ISNI|0000000044689314 | ||
996 | ‡2 PTBNP|1347517 | ||
996 | ‡2 DNB|115834886X | ||
996 | ‡2 PTBNP|1424565 | ||
996 | ‡2 DNB|1198285877 | ||
996 | ‡2 BLBNB|000187499 | ||
996 | ‡2 J9U|987007379212705171 | ||
996 | ‡2 PTBNP|1841971 | ||
996 | ‡2 BLBNB|000294985 | ||
996 | ‡2 SUDOC|242141137 | ||
996 | ‡2 DNB|1255856416 | ||
996 | ‡2 BLBNB|001575452 | ||
996 | ‡2 NTA|312844018 | ||
996 | ‡2 ISNI|0000000079583691 | ||
996 | ‡2 BLBNB|000273678 | ||
996 | ‡2 LC|n 93070163 | ||
996 | ‡2 PTBNP|1651344 | ||
996 | ‡2 SUDOC|254941079 | ||
996 | ‡2 LC|n 2014205042 | ||
996 | ‡2 BLBNB|000334917 | ||
996 | ‡2 ISNI|0000000068377569 | ||
996 | ‡2 CAOONL|ncf11604274 | ||
996 | ‡2 LC|no2022075088 | ||
996 | ‡2 LC|no2012089018 | ||
996 | ‡2 DNB|1057183385 | ||
996 | ‡2 PTBNP|1408451 | ||
996 | ‡2 LC|nb2019004551 | ||
996 | ‡2 PTBNP|1768055 | ||
996 | ‡2 PTBNP|1435916 | ||
996 | ‡2 LC|no2021067465 | ||
996 | ‡2 LC|no2001064274 | ||
996 | ‡2 LC|no2007135473 | ||
996 | ‡2 PTBNP|260538 | ||
996 | ‡2 LC|n 2015238079 | ||
996 | ‡2 DNB|1314332953 | ||
996 | ‡2 PTBNP|1585539 | ||
996 | ‡2 PTBNP|1109873 | ||
996 | ‡2 PTBNP|1439409 | ||
996 | ‡2 BLBNB|000580798 | ||
996 | ‡2 ISNI|0000000050480840 | ||
996 | ‡2 ISNI|0000000067631473 | ||
996 | ‡2 PTBNP|1749771 | ||
996 | ‡2 BLBNB|001532131 | ||
996 | ‡2 ISNI|0000000453914877 | ||
996 | ‡2 BLBNB|001411603 | ||
996 | ‡2 DNB|1190605465 | ||
996 | ‡2 BNC|981058519142706706 | ||
996 | ‡2 LC|n 2015235744 | ||
996 | ‡2 PTBNP|1793207 | ||
996 | ‡2 LC|no2022011390 | ||
996 | ‡2 BLBNB|000377772 | ||
996 | ‡2 ISNI|0000000068118524 | ||
996 | ‡2 ISNI|000000007803835X | ||
996 | ‡2 BLBNB|000592071 | ||
996 | ‡2 PTBNP|1444299 | ||
996 | ‡2 LC|n 2005177857 | ||
996 | ‡2 ISNI|0000000070193590 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |